metricas
covid
Clínica e Investigación en Arteriosclerosis (English Edition) PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol targ...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
PCSK9 inhibitors tug of war: Compliance, adverse events and LDL-cholesterol target
El tira y afloja de los inhibidores de PCSK9: cumplimiento, efectos adversos y objetivo de colesterol LDL
Francesco Sbrana
Corresponding author
francesco.sbrana@ftgm.it

Corresponding author.
, Beatrice Dal Pino
U.O. Lipoapheresis and Center for Inherited Dyslipidemias, Fondazione Toscana Gabriele Monasterio, Via Moruzzi, 1, 56124 Pisa, Italy
Read
Not available
Times
was read the article
Total PDF
Total HTML
Share statistics
Article information
ISSN: 25299123
Original language: English
The statistics are updated each day

Follow this link to access the full text of the article